Diagnosis and Management of Depression in
the Primary Care Setting

Wayne Katon, MD

Module 1: Epidemiology and Impact of Depression

Module 2: Diagnostic and Monitoring Tools

Module 3: Other Mood Disorders

Module 4: Phases of Treatment

Introduction

A significant challenge facing primary care physicians is the recognition of depression in many of their patients. When the diagnosis is made and treatment initiated, physicians are faced with the reality that discontinuation of medication is high during the first three months of treatment. Successful treatment will require patient follow-up and optimal adjustment of medication dosage to achieve remission. The following program presented by Wayne Katon, MD, University of Washington School of Medicine provides an overview of the scope of depression in primary care, a discussion of diagnostic and monitoring tools, and a review of the phases of treatment.

Intended Audience

This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with major depressive disorder.

Educational Objectives

After completing this activity, participants should be better able to:

Describe the individual, societal and economic impact of depression.
Utilize assessment and screening tools (e.g., PHQ-9) to assist in recognizing and diagnosing depressive disorders.
Distinguish depression from other related mental health disorders.
Outline the three phases of depression management and identify critical elements of each phase.

Information on CME credit

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Medical Association designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nonphysicians may receive a certificate of participation for completing this activity.

Instructions for CME credit

These online enduring materials are presented as video webcasts with attendant slide presentation. To receive credit, please view all of the presentations of these CME activities and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.

The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.

Advisory Board

Wayne Katon, MD
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA

Michael S. Klinkman, MD
Associate Professor, Department of Medicine
Associate Professor, Department of Psychiatry
Department of Family Medicine
Director, Primary Care Programs
University of Michigan Depression Center
Ann Arbor, MI

Kurt Kroenke, MD
Professor of Medicine
Indiana University School of Medicine
Research Scientist, Regenstrief Institute, Inc.
Indianapolis, IN

John Williams, MD
Associate Professor of Medicine and Psychiatry
General Medicine
Duke University School of Medicine
Durham, NC

Editorial Board

R. Mark Evans, PhD
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Kristi Eidsvoog, PhD
Content Manager
MedEd Architects, LLC
Chicago, IL

Patti Fitzgerald
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Faculty

Disclosure Policy

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.

These materials have been peer-reviewed by the members of the CME Advisory Board and the AMA Editorial Board to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final content.

Dr. Katon: Advisory Board, Lilly, Wyeth; Speakers Bureau, Pfizer, Forest, GlaxoSmithKline

Dr. Klinkman: Advisory Board, Wyeth; Research Grant, Lilly; Independent Contractor, GE/Healthology

Dr. Kroenke: Research Grant, Lilly, Pfizer, Wyeth; Consultant, Lilly, Pfizer, Wyeth

Dr. Susman: Advisory Board, Pfizer, Forest, Wyeth; Consultant, Pfizer, Forest, Wyeth; Speaker???s Bureau, Pfizer, Forest Wyeth

Dr. Williams: Nothing relevant to disclose

Dr. Evans: Nothing relevant to disclose

Dr. Eidsvoog: Nothing relevant to disclose

Ms. Fitzgerald: Nothing relevant to disclose

Acknowledgement of Support

These CME offerings are supported through an independent education grant from Eli Lilly and Company, and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.